Also published in GlobeNewswire:
Rand Logistics Announces Organizational and Corporate Governance Changes
x hide permanently

Chembio Diagnostics Announces Election of Leslie Teso-Lichtman to Its Board of Directors


Chembio Diagnostics, Inc. (Chembio) (Nasdaq: CEMI), a leading point-of-care diagnostic company focused on infectious diseases, today announced the election of Leslie Teso-Lichtman to its Board of Directors at Chembio’s 2022 Annual Meeting of Stockholders...

Mentions: Annual Meeting Nasdaq Board